Page last updated: 2024-08-22

aluminum sulfate and HIV

aluminum sulfate has been researched along with HIV in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Du, L; Guan, J; He, Y; Jiang, S; Liang, C; Lustigman, S; Xiao, W; Zhou, Y	1

Other Studies

1 other study(ies) available for aluminum sulfate and HIV

Article	Year
Evaluation of recombinant Onchocerca volvulus activation associated protein-1 (ASP-1) as a potent Th1-biased adjuvant with a panel of protein or peptide-based antigens and commercial inactivated vaccines. Vaccine, 2008, Sep-15, Volume: 26, Issue:39 Topics: Adjuvants, Immunologic; Alum Compounds; Animals; Antibodies, Viral; Helminth Proteins; Hepatitis B Surface Antigens; Hepatitis B virus; HIV; HIV Envelope Protein gp41; Immunoglobulin G; Male; Mice; Mice, Inbred BALB C; Onchocerca volvulus; Ovalbumin; Recombinant Proteins; Th1 Cells; Vaccines, Inactivated; Vaccines, Synthetic; Viral Vaccines	2008

Article

Year

Evaluation of recombinant Onchocerca volvulus activation associated protein-1 (ASP-1) as a potent Th1-biased adjuvant with a panel of protein or peptide-based antigens and commercial inactivated vaccines.

Vaccine, 2008, Sep-15, Volume: 26, Issue:39

Topics: Adjuvants, Immunologic; Alum Compounds; Animals; Antibodies, Viral; Helminth Proteins; Hepatitis B Surface Antigens; Hepatitis B virus; HIV; HIV Envelope Protein gp41; Immunoglobulin G; Male; Mice; Mice, Inbred BALB C; Onchocerca volvulus; Ovalbumin; Recombinant Proteins; Th1 Cells; Vaccines, Inactivated; Vaccines, Synthetic; Viral Vaccines

2008